Table 6 Scenario analyses in patient subgroups
From: A telemonitoring programme in patients with heart failure in France: a cost-utility analysis
Life years | QALYs | Total costs (€) | ICER (€/LY) | ICER (€/QALY) | |
|---|---|---|---|---|---|
Base case | |||||
SCAD | 6.03 | 4.41 | 35,177 | ||
SC | 5.11 | 3.75 | 30,932 | 4579 | 6491 |
Difference | 0.93 | 0.65 | 4245 | ||
Preserved ejection fraction | |||||
SCAD | 5.88 | 4.24 | 34,707 | ||
SC | 4.87 | 3.54 | 30,628 | 4045 | 5843 |
Difference | 1.01 | 0.70 | 4079 | ||
Mid-range ejection fraction | |||||
SCAD | 6.19 | 4.54 | 34,107 | ||
SC | 5.29 | 3.90 | 29,821 | 4741 | 6625 |
Difference | 0.90 | 0.65 | 4287 | ||
Reduced ejection fraction | |||||
SCAD | 6.00 | 4.32 | 35,781 | ||
SC | 5.03 | 3.65 | 31,448 | 4474 | 6431 |
Difference | 0.97 | 0.67 | 4332 | ||
NYHA Class I/II | |||||
SCAD | 6.66 | 5.16 | 34,694 | ||
SC | 5.87 | 4.55 | 30,144 | 5779 | 7500 |
Difference | 0.79 | 0.61 | 4550 | ||
NYHA Class III/IV | |||||
SCAD | 5.06 | 3.23 | 35,933 | 3289 | 5176 |
SC | 3.91 | 2.51 | 32,164 | ||
Difference | 1.15 | 0.73 | 3769 | ||